0001161697-21-000393.txt : 20210819 0001161697-21-000393.hdr.sgml : 20210819 20210819170754 ACCESSION NUMBER: 0001161697-21-000393 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210817 FILED AS OF DATE: 20210819 DATE AS OF CHANGE: 20210819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANDE ALICIA CENTRAL INDEX KEY: 0001402652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 211190986 MAIL ADDRESS: STREET 1: 220 MIRACLE MILE STREET 2: SUITE 234 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 08-17-2021 X0306 4 2021-08-17 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001402652 GRANDE ALICIA 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 VP, Treasurer and CFO Common stock, par value $0.001 per share 2021-08-17 4 M 0 100000 3.12 A 507441 D Common stock, par value $0.001 per share 2021-08-17 4 S 0 100000 5.669 D 407441 D Common stock, par value $0.001 per share 2021-08-18 4 M 0 70000 3.12 A 477441 D Common stock, par value $0.001 per share 2021-08-18 4 S 0 13000 5.683 D 464441 D Options to purchase common stock 3.12 2021-08-17 4 M 0 100000 0 D 2021-08-28 Common Stock 100000 1391334 D Options to purchase common stock 3.12 2021-08-18 4 M 0 70000 0 D 2021-08-28 Common Stock 70000 1321334 D Shares were sold in various lots from $5.62 to $5.725 per share. The listed sale price represents a weighted average price for the shares sold. Shares were sold in various lots from $5.65 to $5.785 per share. The listed sale price represents a weighted average price for the shares sold. Shares were sold to cover exercise price of options and tax withholding requirements. Options vested in three annual tranches beginning on August 28, 2015. /s/ Alicia Grande 2021-08-19